BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18722466)

  • 1. Impact of retinal disease-associated RPE65 mutations on retinoid isomerization.
    Bereta G; Kiser PD; Golczak M; Sun W; Heon E; Saperstein DA; Palczewski K
    Biochemistry; 2008 Sep; 47(37):9856-65. PubMed ID: 18722466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal.
    Samardzija M; von Lintig J; Tanimoto N; Oberhauser V; Thiersch M; Remé CE; Seeliger M; Grimm C; Wenzel A
    Hum Mol Genet; 2008 Jan; 17(2):281-92. PubMed ID: 17933883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.
    Redmond TM; Poliakov E; Yu S; Tsai JY; Lu Z; Gentleman S
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13658-63. PubMed ID: 16150724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.
    Bowne SJ; Humphries MM; Sullivan LS; Kenna PF; Tam LC; Kiang AS; Campbell M; Weinstock GM; Koboldt DC; Ding L; Fulton RS; Sodergren EJ; Allman D; Millington-Ward S; Palfi A; McKee A; Blanton SH; Slifer S; Konidari I; Farrar GJ; Daiger SP; Humphries P
    Eur J Hum Genet; 2011 Oct; 19(10):1074-81. PubMed ID: 21654732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rpe65 is a retinyl ester binding protein that presents insoluble substrate to the isomerase in retinal pigment epithelial cells.
    Mata NL; Moghrabi WN; Lee JS; Bui TV; Radu RA; Horwitz J; Travis GH
    J Biol Chem; 2004 Jan; 279(1):635-43. PubMed ID: 14532273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.
    Cideciyan AV; Aleman TS; Boye SL; Schwartz SB; Kaushal S; Roman AJ; Pang JJ; Sumaroka A; Windsor EA; Wilson JM; Flotte TR; Fishman GA; Heon E; Stone EM; Byrne BJ; Jacobson SG; Hauswirth WW
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15112-7. PubMed ID: 18809924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa.
    Kiang AS; Kenna PF; Humphries MM; Ozaki E; Koenekoop RK; Campbell M; Farrar GJ; Humphries P
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33261050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPE65 gene: multiplex PCR and mutation screening in patients from India with retinal degenerative diseases.
    Joseph B; Srinivasan A; Soumittra N; Vidhya A; Shetty NS; Uthra S; Kumaramanickavel G
    J Genet; 2002 Apr; 81(1):19-23. PubMed ID: 12357075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.
    Booij JC; Florijn RJ; ten Brink JB; Loves W; Meire F; van Schooneveld MJ; de Jong PT; Bergen AA
    J Med Genet; 2005 Nov; 42(11):e67. PubMed ID: 16272259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
    Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.
    Choi EH; Suh S; Sander CL; Hernandez CJO; Bulman ER; Khadka N; Dong Z; Shi W; Palczewski K; Kiser PD
    Hum Mol Genet; 2018 Jul; 27(13):2225-2243. PubMed ID: 29659842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular analysis of the RPE65 gene in 72 Spanish families with autosomal recessive retinitis pigmentosa].
    Marcos I; Ruiz A; Borrego S; Ayuso C; Baiget M; Antiñolo G
    Med Clin (Barc); 2001 Jun; 117(4):121-3. PubMed ID: 11472682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of two point mutations of RPE65 from Leber's congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65.
    Chen Y; Moiseyev G; Takahashi Y; Ma JX
    FEBS Lett; 2006 Jul; 580(17):4200-4. PubMed ID: 16828753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.
    Morimura H; Fishman GA; Grover SA; Fulton AB; Berson EL; Dryja TP
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3088-93. PubMed ID: 9501220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cone photoreceptor dependence on RPE65 isomerase.
    Jacobson SG; Aleman TS; Cideciyan AV; Heon E; Golczak M; Beltran WA; Sumaroka A; Schwartz SB; Roman AJ; Windsor EA; Wilson JM; Aguirre GD; Stone EM; Palczewski K
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15123-8. PubMed ID: 17848510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetics of pigmentary retinopathies: identification of mutations in CHM, RDS, RHO, RPE65, USH2A and XLRS1 genes].
    Hamel CP; Griffoin JM; Bazalgette C; Lasquellec L; Duval PA; Bareil C; Beaufrère L; Bonnet S; Eliaou C; Marlhens F; Schmitt-Bernard CF; Tuffery S; Claustres M; Arnaud B
    J Fr Ophtalmol; 2000 Dec; 23(10):985-95. PubMed ID: 11139690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Leu/Met variation at residue 450 on isomerase activity and protein expression of RPE65 and its modulation by variation at other residues.
    Redmond TM; Weber CH; Poliakov E; Yu S; Gentleman S
    Mol Vis; 2007 Sep; 13():1813-21. PubMed ID: 17960118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation.
    Lorenz B; Poliakov E; Schambeck M; Friedburg C; Preising MN; Redmond TM
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5235-42. PubMed ID: 18599565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.